Yellow fever vaccine safe and effective in HIV-positive individuals with CD4 count above 200

This article is more than 20 years old. Click here for more recent articles on this topic

p>The yellow fever vaccine is effective and safe in HIV-positive individuals with a CD4 cell count above 200 cells/mm3, according to a retrospective French study published in the March 25th edition of AIDS.

Yellow fever is a potentially fatal mosquito-borne viral infection which can be effectively prevented with the yellow fever 17D vaccine. However, as this is a live-attenuated vaccine, there have been concerns that it cannot be safely given to HIV-positive individuals, as there is a theoretical risk of prolonged yellow fever virus replication, which could infect the brain and cause organ damage. In addition, a study in asymptomatic HIV-positive children suggested that the yellow fever vaccine might not provide effective immunisation.

In 2002, however, it was recommended in the US that HIV-positive individuals with CD4 cell counts above 200 cells/mm3 should be vaccinated if travelling to Africa or South America ,where yellow fever is endemic.

Glossary

retrospective study

A type of longitudinal study in which information is collected on what has previously happened to people - for example, by reviewing their medical notes or by interviewing them about past events. 

p-value

The result of a statistical test which tells us whether the results of a study are likely to be due to chance and would not be confirmed if the study was repeated. All p-values are between 0 and 1; the most reliable studies have p-values very close to 0. A p-value of 0.001 means that there is a 1 in 1000 probability that the results are due to chance and do not reflect a real difference. A p-value of 0.05 means there is a 1 in 20 probability that the results are due to chance. When a p-value is 0.05 or below, the result is considered to be ‘statistically significant’. Confidence intervals give similar information to p-values but are easier to interpret. 

neutralising antibody

An antibody that neutralises (renders harmless) an infectious microorganism.

immunisation

Immunisation is the process whereby a person is made immune or resistant to an infectious disease, typically by the administration of a vaccine. Vaccines stimulate the body’s own immune system to protect the person against subsequent infection or disease.

 

immune response

The immune response is how your body recognises and defends itself against bacteria, viruses and substances that appear foreign and harmful, and even dysfunctional cells.

French investigators conducted a retrospective study involving twelve HIV-positive individuals who received the 17D yellow fever vaccine prior to travel between 1995 and 2002, to see if the vaccination produced an effective antibody response and was well tolerated.

Nine of the patients were women, and the mean age was 39 years. Two individuals had been diagnosed with an AIDS-defining illness prior to being vaccinated against yellow fever. At the time of vaccination, mean CD4 cell count was 561 cells/mm3, and mean viral load was 5,477 copies/ml. Nine patients were taking antiretroviral therapy at the time of immunization, and five had a viral load below 200 copies/ml.

All the patients developed a good immune response to the vaccine, with a mean yellow fever neutralizing antibody titre of 1/40. CD4 cell counts and viral load tests were available for ten patients three months after the use of the vaccine. There was no significant change in CD4 cell count (p=0.6), or viral load (p=0.2) from baseline, and all five patients who had an undetectable viral load at baseline remained undetectable after receiving the vaccine.

One patient developed a transient fever and sore throat five days after receiving the vaccine. No serious adverse events were recorded.

The investigators conclude yellow fever vaccine “appears to be safe and effective in HIV-infected patients with CD4 cell counts above 200 cells/mm3, even if they have previously developed AIDS or if their viral load is above 10,000 copies/ml.”

Further information on this website

Vaccinations and immunisations - overview

References

Tattevin P et al. Yellow fever vaccine is safe and effective in HIV infected patients. AIDS 18: 825-827, 2004.